Health Care Deal News-Februrary 13, 2012


Brought to you by

February 13, 2012 Issue:


  1. Recent Health Care M&A Deals
  2. 2012 M&A Sprints Out Of Gate--
    Posts Record Deal Volume In January
  3. Spotlight on: Biotechnology
  4. Conference Calendar



Recent Health Care M&A Deals





Cytomedix, Inc.

Aldagen, Inc.

$44.0 million

Shire plc

Collaboration agreement for monogenic diseases (Sangamo BioSciences, Inc.)

$13.0 million +





Not disclosed

Secure eHealth, LLC (Wound Management Technologies, Inc.)


Medical Devices




Syneron Medical Ltd.

Ultrashape Ltd.

$12.0 million





Walgreen Co.

BioScrip business units

$285.0 million



Get Two Reports for the Price of One ($595 savings)!
Deals have been made. The 2012 Health Care Services Acquisition Report contains knowledge that is crucial to the success of your business, your investments, and your clients. Take advantage of our limited-time 2 for 1 offer—Extended to orders placed through March 31! Buy our 2012 Health Care Services Acquisition Report and receive The 2011 Health Care Services Acquisition Report free! Now that’s a recession resistant deal. Place your order by 3/31 by calling 1-800-248-1668 or order online at


2012 M&A Sprints Out Of Gate--
Posts Record Deal Volume In January

January 2012 posted record deal volume in the health care merger and acquisition market. The majority of this action is taking place in the middle market, which is often overlooked in the general media. This activity appears to be supported by the Federal Reserve’s recent decision to keep short-term interest rates low, thus bringing a measure of stability to the marketplace...Read more 


Is Your Company a Power User of Merger and Acquisition Data?
Drive the price of data down to less than 3 cents per item. Call 1-800-248-1668 to learn about our frequency discounts. Go to, an easy-to-use, award-winning database. This specialized database is an essential 24/7 source for details on health care mergers and acquisitions covering 13 sectors. With over 17,000 records of investments and contact names (including e-mail addresses), you’ll get the information you need to make an informed decision any time of the day or night. Call 1-800-248-1668 to learn about our frequency discounts.


Spotlight on: Biotechnology
In January’s largest Biotechnology deal, Amgen, Inc. (NASDAQ: AMGN) is acquiring Micromet, Inc. (NASDAQ: MITI) for approximately $1.16 billion. Based in Rockville, Maryland, MITI discovers, develops and commercializes antibody-based therapeutics to treat cancer. On a trailing 12-month basis, the company generated revenue of $26.4 million and a net loss of $58.0 million. AMGN is offering to pay $11.00 per share, or $1.16 billion...Read more

Conference Calendar...Click here to see more